Two Cases of Bullous Pemphigoid Induced by Vildagliptin

Creative Commons License

Unal A. D., Tarcin Ö., Demirci G. T., Demiralay E., Mansur A. T., Yildiz S., ...More

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, vol.22, no.3, pp.198-203, 2018 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.25179/tjem.2017-56526
  • Journal Name: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.198-203
  • Keywords: Diabetes mellitus, bullous pemphigoid, vildagliptin, GROWTH
  • Marmara University Affiliated: Yes

Abstract

Purpose: Bullous pemphigoid is an autoimmune blistering disorder that commonly develops in elderly subjects who are prone to an increased risk of mortality and morbidity. Although a few cases of dipeptidyl peptidase-4 inhibitors have been reported earlier, the etiology of bullous pemphigoid is not entirely clear.